Agios Pharmaceuticals, Inc.
USD38.04
+0.14 (+0.37%)
CEO
Brian Goff
IPO Date
2013-07-24
Sector
Healthcare
Industry
Biotechnology
Exchange
NASDAQ
Country
US
Open
$37.58
Prev. Close
$37.90
Day Low
$37.58
Day High
$38.08
52W Low
$22.24
52W High
$46.00
Market Cap
$2.26B
Volume
0.77M
| 2.8 |
| 31 Dec 2023 | FY | 64.6% | -1312.6% | -43.4% | -37.6% | 0.09 | 12.27 | -3.5 |
| 31 Dec 2022 | FY | 88.0% | -1627.8% | -21.1% | -18.7% | 0.08 | 13.30 | -6.6 |
| 31 Dec 2021 | FY | 0.0% | 0.0% | 124.2% | 111.6% | 0.08 | 17.79 | 1.2 |
| 31 Dec 2020 | FY | 0.0% | 0.0% | -81.9% | -38.4% | 0.26 | 6.74 | -9.1 |
| 31 Dec 2019 | FY | 98.9% | -349.0% | -64.2% | -46.2% | 0.18 | 6.59 | -7.0 |
| 31 Dec 2018 | FY | 98.5% | -366.6% | -50.3% | -40.3% | 0.00 | 6.56 | -7.7 |
| 31 Dec 2017 | FY | -580.5% | -731.6% | -83.8% | -51.2% | 0.00 | 4.69 | -8.5 |
| 31 Dec 2016 | FY | -215.0% | -284.0% | -55.3% | -32.1% | 0.00 | 6.33 | -8.2 |
| -3.7 |
| 30 Sept 2025 | Q3 | 76.3% | -803.1% | -8.1% | -7.5% | 0.03 | 13.82 | -5.6 |
| 30 Jun 2025 | Q2 | 76.2% | -899.4% | -8.2% | -7.6% | 0.04 | 14.48 | -4.3 |
| 31 Mar 2025 | Q1 | 72.9% | -1023.3% | -6.1% | -5.7% | 0.04 | 18.50 | -4.7 |
| 31 Dec 2024 | Q4 | 88.3% | -899.6% | -6.3% | -5.8% | 0.04 | 11.90 | -4.9 |
| 30 Sept 2024 | Q3 | 91.3% | 10574.7% | 58.3% | 52.9% | 0.04 | 8.99 | 0.7 |
| 30 Jun 2024 | Q2 | 64.2% | -1115.7% | -14.6% | -12.4% | 0.10 | 10.09 | -6.4 |
| 31 Mar 2024 | Q1 | 75.9% | -995.8% | -11.0% | -9.6% | 0.09 | 12.84 | -5.0 |
| 31 Dec 2023 | Q4 | 72.0% | -1350.7% | -11.8% | -10.2% | 0.09 | 12.27 | -3.2 |